下载后可任意编辑乙酰半胱氨酸联合丙酸倍氯米松雾化吸入治疗毛细支气管炎的临床效果乙酰半胱氨酸联合丙酸倍氯米松雾化吸入治疗毛细支气管炎的临床效果 史军然 杜杰静 高虹 [摘要]目的 探討乙酰半胱氨酸联合丙酸倍氯米松雾化吸入治疗毛细支气管炎的临床效果。方法 选取 20XX 年 2 月~20XX 年 2 月我院收治的 306 例毛细支气管炎患儿作为讨论对象,根据电子病历的自然排序,将其分为治疗 A 组(106例)、治疗 B 组(100 例)和对比组(100 例)。所有患儿均给予常规治疗措施。治疗 A 组患儿采纳乙酰半胱氨酸联合丙酸倍氯米松雾化吸入治疗。治疗 B 组患儿采纳丙酸倍氯米松联合沙丁胺醇雾化吸入治疗。对比组患儿采纳沙丁胺醇雾化吸入治疗。比较三组患儿的喘息、喘鸣音、三凹征消逝时间,观察三组患儿的治疗效果及不良反应发生情况。结果 治疗 A 组患儿的喘息、喘鸣音及三凹征消逝时间均短于治疗 B 组和对比组,治疗 B 组患儿的喘息、喘鸣音及三凹征消逝时间均短于对比组,差异有统计学意义(P0.05)。三组患儿治疗过程中均未发生严重不良反应。结论 采纳乙酰半胱氨酸联合丙酸倍氯米松雾化吸入治疗毛细支气管炎,可缩短患儿的临床症状消逝时间,提高临床治疗效果,不良反应少,安全性好,值得临床推广应用。 [关键词]毛细支气管炎;雾化吸入;乙酰半胱氨酸;丙酸倍氯米松 [Abstract] Objective To investigate the clinical effect of aerosol inhalation of Acetylcysteine combined with Beclomethasone Dipropionate in the treatment of capillary bronchitis. Methods A total of 306 patients with capillary bronchitis treated in our hospital from February 20XX to February 20XX were selected as the research subjects. According to the sequence of electronic medical records , they were divided into treatment-A group ( n=106 ) , treatment-B group ( n=100 ) , and control group ( n=100 ) . All children were given routine treatment. In the treatment-A group , 1下载后可任意编辑aerosol inhalation of Acetylcysteine combined with Beclomethasone Dipropionate was used. In the treatment-B group, aerosol inhalation of Salbutamol combined with B...